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ZebraﬁshThe lysosomal hydrolase galactocerebrosidase (GALC) catalyzes the removal of galactose from galactosylceramide
and from other sphingolipids. GALC deﬁciency is responsible for globoid cell leukodystrophy (GLD), or Krabbe's
disease, an early lethal inherited neurodegenerative disorder characterized by the accumulation of the neurotoxic
metabolite psychosine in the central nervous system (CNS). The poor outcome of current clinical treatments calls
for novel model systems to investigate the biological impact of GALC down-regulation and for the search of novel
therapeutic strategies inGLD. Zebraﬁsh (Danio rerio) represents an attractive vertebratemodel for humandiseases.
Here, lysosomal GALC activity was demonstrated in the brain of zebraﬁsh adults and embryos. Accordingly, we
identiﬁed two GALC co-orthologs (named galca and galcb) dynamically co-expressed in CNS during zebraﬁsh
development. Both genes encode for lysosomal enzymes endowed with GALC activity. Single down-regulation
of galca or galcb by speciﬁc antisense morpholino oligonucleotides results in a partial decrease of GALC activity
in zebraﬁsh embryos that was abrogated in double galca/galcbmorphants. However, no psychosine accumulation
was observed in galca/galcb doublemorphants. Nevertheless, double galca/galcb knockdown caused reduction and
partial disorganization of the expression of the early neuronal marker neuroD and an increase of apoptotic events
during CNS development. These observations provide new insights into the pathogenesis of GLD, indicating that
GALC loss-of-function may have pathological consequences in developing CNS independent of psychosine accu-
mulation. Also, they underscore the potentiality of the zebraﬁsh system in studying the pathogenesis of lysosomal
neurodegenerative diseases, including GLD.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Lysosomal storage disorders represent one of the most frequent
classes of human genetic diseases. Galactocerebrosidase (GALC; EC
3.2.1.46) [1] is a lysosomal acid hydrolase that catalyzes the removal
of galactose from galactosylceramide (GalCer), a major component of
myelin, and from other terminal β-galactose-containing sphingolipids,boid cell leukodystrophy; CNS,
, morpholino oligonucleotide;
sine
d Translational Medicine, Viale
x: +39 30 3717747.
ights reserved.including galactosyl-sphingosine (psychosine). Genetic GALCdeﬁciency
causes globoid cell leukodystrophy (GLD), or Krabbe's disease (OMIM
#245200), an autosomal recessive sphingolipidosis characterized by
degeneration of oligodendroglia and progressive demyelination. The
pathogenesis of the disease has been proposed to arise from the accu-
mulation of the neurotoxic GALC metabolite psychosine detectable at
high levels in the central nervous system (CNS) of GLD patients [2–4].
Clinically, GLD manifests in early infancy and results in a severe
neurological dysfunction that often leads to death by 2 years of age
[5–7]. At present, the only clinical treatment for GLD is bone marrow or
umbilical cord blood cell transplantation for late-onset and presymptom-
atic patients [7,8]. Thus, novel model systemsmay provide an invaluable
tool for investigating the molecular mechanisms underlying GLD in the
search for effective therapeutic interventions. The twitchermouse is an
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and biochemical bases of the disease and as a model system for novel
therapeutic approaches [9–12]. Nevertheless, such studies in mice can
be relatively slow, laborious and expensive to perform. Also, the intra-
uterine gestationmakes it difﬁcult to follow possible alterations in devel-
opmental processes consequent to the lack of GALC activity.
When compared to other vertebrate models, zebraﬁsh (Danio rerio)
offers several features that make this freshwater ﬁsh an attractive
vertebrate systemto investigate themechanismsof humandiseases alter-
native to mouse [13,14]. The nervous system in zebraﬁsh is well charac-
terized and considered suitable for comparison to humans [15,16],
making zebraﬁsh a possible alternative organism to investigate human
neurodegenerative and lysosomal storage diseases [16–19]. Also, a com-
prehensive collection of reverse genetics tools have been developed for
studying gene function in this useful organism. Microinjection of anti-
sense morpholino oligonucleotides (MOs) into one cell embryos can be
used to assess the effect of transient gene down-regulation on early
zebraﬁsh development [20,21]. Moreover, engineered endonucleases,
including ZFNs (zinc ﬁnger nucleases), TALENs (transcription activator-
like effector nucleases) and clustered, regularly interspaced, short palin-
dromic repeats (CRISPR)–CRISPR-associated (Cas) systems, have been
shown to provide new and efﬁcient strategies to achieve directly site-
speciﬁc genome modiﬁcation in zebraﬁsh [22,23].
In the present study, lysosomal GALC activity was demonstrated in
the brain of zebraﬁsh adults and embryos. Accordingly, in silico analysis
identiﬁed two zebraﬁsh gene orthologs to mammalian GALC (named
galca and galcb). Both genes encode for lysosomal enzymes active at acidic
pH when transduced in HEK cells. Whole-mount in situ hybridization
(WISH) experiments demonstrated that galca and galcb are expressed
in CNS during zebraﬁsh development. Following speciﬁc MO injection,
galca/galcb double morphants were characterized by the complete
down-regulation of GALC activity in zebraﬁsh embryos. However, no
psychosine accumulationwas observed in galca/galcbdoublemorphants
that did not show major phenotypic developmental alterations. Never-
theless, double galca/galcb knockdown caused the reduction and partial
disorganization in the expression of the neuronal marker neuroD [24]
and an increase of apoptotic events in developing zebraﬁsh CNS, indi-
cating that GALC loss-of-function may have pathological consequences
in developing CNS independent of psychosine accumulation. These
observations, together with the lack of lethal embryonic defects in
zebraﬁsh morphants, set the bases for future studies aimed at investi-
gating the effect of stable galca/galcb gene knock-out in zebraﬁsh for
the study of the pathogenesis of GLD and for the search of efﬁcacious
therapeutic strategies.
2. Materials and methods
2.1. Zebraﬁsh maintenance and collection
All embryos were handled according to relevant national and inter-
national guidelines. Current Italian rules do not require approval for
research on zebraﬁsh embryos. The wild type zebraﬁsh AB strain was
maintained at 28 °C on a 14 h light/10 h dark cycle under standard lab-
oratory conditions as described in the Zebraﬁsh Book [25]. Immediately
after spawning, the fertilized eggs were harvested, washed and placed
in 10 cm Ø Petri dishes in ﬁsh water. The developing embryos were
incubated at 28 °C. Embryos at different stages were maintained in
0.003% 1-phenyl-2-thiourea (Sigma) to prevent pigmentation. Embryos
were ﬁxed in 4% paraformaldehyde in PBS overnight at 4 °C, rinsed
twice in 1% Tween-20 in PBS, dehydrated in methanol and stored at
−20 °C until processing [26].
2.2. Bioinformatics analysis and protein modeling
Nucleotide and amino acid sequences were compared to the non-
redundant sequence databases present at the NCBI (National Centerfor Biotechnology Information GenBank Database, http://blast.ncbi.
nlm.nih.gov) using the BLAST algorithm [27]. Sequence similarity
searches against the Zebraﬁsh Jul. 2010 (Zv9/danRer7) genome assembly
wereperformedusingBlat at theUCSCGenomeBrowser (http://genome.
ucsc.edu/). The multiple sequence alignment was generated using
ClustalW [28] and phylogenetic analysis was performed on the
Phylogeny.fr web service. Comparative genomics analysis of Galc
sequences in teleosts was performed using the Ensemble db (http://
www.ensembl.org). Synteny analysis was carried out using the
Genomicus genome browser (http://www.dyogen.ens.fr/genomicus-72.
01) [29].
Structuralmodels of D. rerioGalca and Galcb proteinswere obtained
by similaritymodeling using I-Tasser (PMID: 20360767) and the known
crystal structure of the mouse GALC protein as template (pdb entry:
3zr6). The predicted models with the lowest C-score were selected as
the putative protein structures. Pdb models of Galca and Galcb were
then superimposed on the murine protein structure using PyMOL
(The PyMOL Molecular Graphics System, Version 1.5.0.1 Schrödinger,
LLC).
2.3. Cloning, sequencing and expression of zebraﬁsh galca and galcb genes
Total RNAwas isolated from zebraﬁsh embryos at 4 h post fertilization
(hpf). The full coding regions of galca and galcb genes were ampliﬁed
by RT-PCR using the following speciﬁc primers:
galca: forward, 5′-cagacttcagccgcagttcattg-3′; reverse, 5′-gtacgaatca
ccctgcaatcac-3′;
galcb: forward, 5′-ggaacgcacgggatagaatgtac-3′; reverse, 5′-gtatgggg
tgttattctgcctc-3′.
The RT-PCR products were electrophoresed on 1% agarose gel in 1×
TAE buffer, ethidium bromide stained and then cloned directly into the
pCR®2.1-TOPO vector (Invitrogen). After sequencing veriﬁcation, the
galca cDNA was excised with BstXI and the galcb cDNA was digested
with XbaI and BamHI; the inserts were then subcloned into the pcDNA
3.1 expression vector. The constructs were stably transfected in
HEK293T cells using lipofectamine according to standard protocols.
2.4. GALC activity assays
Routinely, GALC activity was measured as described [30]. Brieﬂy,
10 μg of protein extract (50 μl) were mixed with 100 μl of 1.5 mM
4-methylumbelliferyl-β-D-galactoside substrate (Sigma) resuspended
in 0.1/0.2 M citrate/phosphate buffer, pH 4.0, in the presence of 20 μM
AgNO3 to inhibit β-galactosidase activity. Reactions were incubated
for 30 min at 37 °C, stopped with 0.2 M glycine/NaOH, pH 10.6, and
ﬂuorescence of released 4-methylumbelliferone was measured (λex
360 nm, λem 446 nm). When indicated, GALC-mediated lysis of the
synthetic ﬂuorescent GALC substrate LRh-6-GalCer (N-lissamine
rhodaminyl-6-aminohexanoylgalactosyl ceramide) following its incu-
bationwith 40 μg of tissue extractwas quantiﬁed by thin-layer chroma-
tography as described [31]. In some experiments, the assays were
performed in the presence of a 10-fold more excess of psychosine
or N-acetyl-D-sphingosine (Sigma). In that case, the concentration
of the 4-methylumbelliferyl-β-D-galactoside substrate was equal to
0.2 mM.
2.5. Western blot analysis
Total cell proteins were isolated using the RIPA lysis buffer (50 mM
Tris–HCl, 50mMNaCl, 1% TritonX-100, 1mMEDTA) containing protease
inhibitors, subjected to 3 rounds of sonication, and incubated for 45 min
on ice. Protein content was measured using the Bradford Protein Assay
Kit (BioRad) with bovine serum albumin as the reference standard.
Protein sampleswere subjected to SDS/PAGE [10% (w/v) polyacrylamide
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P blotting membrane (Amersham Biosciences). The membranes were
incubated for 30 min in PBST [PBS containing 0.05% (v/v) Tween 20]
and 5% (w/v) non-fat dried skimmed milk powder (blocking buffer)
and subsequently incubated with a rabbit polyclonal anti-human GALC
antibody (Proteintech, catalog no. 11991-1-AP). After a ﬁnal washing
in PBST and incubation with horseradish-peroxidase-conjugated anti-
rabbit antibody (ThermoScientiﬁc), immunoreactive proteins were visu-
alized using the SuperSignal West Pico chemiluminescence substrate
detection kit (Pierce).2.6. Subcellular fractionation on Percoll gradients
HEK293T transfected cells were washed with PBS/0.25 M sucrose at
4 °C, scraped in 0.25M sucrose/2.5mMTris buffer, pH7.4 (buffer A) and
centrifuged at 800 ×g for 10 min. Cells were resuspended in 1 ml buffer
A, homogenizedwithDounce homogenizer (40 strokes) and centrifuged
at 1200×g for 10min. Thepostnuclear supernatantwas loaded on 10ml
Percoll solution (20% Percoll, 0.25 M sucrose, 5 mM Tris buffer, pH 7.2)
and centrifuged for 30 min at 35,000 ×g in the vertical rotor VTi 65.1
(Beckman Instruments) [32]. In some experiments, brain extracts from
zebraﬁsh adults (200 mg of protein) were prepared in buffer A and
loaded on the top of the Percoll gradient. Then, GALC activity assay
was performed for each fraction and β-hexosaminidase activity was
used as a lysosomal marker.2.7. Quantitative RT-PCR analysis
RNA samples were extracted from zebraﬁsh embryos at different
developmental stages following TRIzol® reagent protocol (Invitrogen)
and treated with RQ1 RNase-Free DNase (Promega). Two micrograms
of total RNA was retrotranscribed with MMLV reverse transcriptase
(Invitrogen), using random hexamers in a ﬁnal volume of 20 μl. Quanti-
tative RT-PCR was performed with a Biorad iCycler iQ™ Real-time PCR
Detection Systemusing a iQ™ SYBRGreen Supermix (BioRad) according
to manufacturer's instructions using the following speciﬁc primers at
400 mM ﬁnal concentration:
galca: forward, 5′-GCGATGGCTCAAACCACAG-3′; reverse, 5′-AAGT
AAGGCCATTGGGTTC-3′;
galcb: forward, 5′-TGGTGGGCGTTTACTTGTC-3′; reverse, 5′-ATGTGT
GAGGGCTCAGTTCC-3′.
Triplicate data were averaged and normalized to an averaged 18S
rRNA endogenous control [33]. Data were analyzed using REST [34].2.8. Immunoﬂuorescence analysis
Sevenmicrometer thick OCT-embedded frozen serial coronal sections
from the brain of zebraﬁsh adults were ﬁxed for 2min in cooled acetone,
air dried, andwashed three timeswith Tris-buffered saline. After blocking
with 1% BSA in PBS plus 0.1% Triton X-100, sections were incubated
overnight at 4 °C with rabbit polyclonal anti-GALC antibody (1:100,
Proteintech) or with rabbit polyclonal anti-GFAP antibody (1:100, Dako
Glostrup), followed by 1 h incubation at room temperature with Alexa
Fluor 488 anti-rabbit IgG antibody (1:250, Invitrogen). For double-
immunolabeling the sections were incubated overnight at 4 °C with
anti-GALC antibody (1:100) and a mouse monoclonal anti-GAD67 anti-
body (1:100, Millipore, clone 1G10.2), followed by 1 h incubation with
Alexa Fluor 488 anti-rabbit IgG antibody (1:250) plus Alexa Fluor 594
anti-mouse IgG antibody (1: 250). Nuclei were counterstained with 4,6-
diamidino-2-phenylindole (DAPI, Sigma). Images were acquired using
an Axiovert 200 microscope (Zeiss) equipped with ApoTome optical
sectioning device (Zeiss).2.9. Whole-mount in situ hybridization
Antisense and sense riboprobes were prepared by in vitro tran-
scribed linearized cDNA clones with T7 and SP6 polymerase using
Digoxigenin Labeling Mix (Roche). The probes speciﬁc for galca and
galcb genes were selected in order to avoid cross hybridization between
the two genes using the following speciﬁc primers:
galca: forward, 5′-gcactttgacgtctctcc-3′; reverse, 5′-agataaagttccta
gagcag-3′;
galcb: forward, 5′-ggtgggagttacgttgcact-3′; reverse, 5′-gagcactgcatt
cttccaca-3′.
For the galca probe a PCR fragment of 840 bp and for galcb probe a
PCR fragment of 863 bp were subcloned in the pCR®2.1-TOPO vector
(Invitrogen). The anti-sense probes for galca and galcb containing the
ATG were synthesized with T7 polymerase by transcribing the SalI-
linearized galcapCR2.1-TOPO and the HindIII-linearized galcbpCR2.1-
TOPO vectors, respectively.
Whole-mount in situ hybridization (WISH) was carried out as
described [35]. After ﬁxation, 0.003% 1-phenyl-2-thiourea-treated
embryos at different developmental stages were permeabilized with
Proteinase K (10 μg/ml, Sigma) and hybridized overnight at 68 °C in
formamide buffer with Digoxigenin-Labeled RNA antisense or sense
probes. After several washes at high stringent temperature, NBT/BCIP
(Roche) stainingwas performed according tomanufacturer's instructions.
Embryos weremounted in agarose-coated dishes and images were taken
with a Leica MZ16F stereomicroscope equipped with DFC 480 digital
camera and LAS Leica Imaging software (Leica, Wetzlar, Germany).
2.10. Morpholino knockdown
Speciﬁc MOs (Gene Tools, Philomath, OR) were designed targeting
the exon 3 of zebraﬁsh galca and galcb genes:
galca: MO 5′-TACTTTGCTTCACCTGTGGTTT-3′;
galcb: MO 5′-GCAGAGTTTACCTGTAGTCTG-3′.
MOs, diluted in Danieau buffer, were injected at the 1–2-cell stage.
Increasing doses of each MO were tested for phenotypic effects; as
control for nonspeciﬁc effects, experiments were performed in parallel
with a standard control MO (std MO) (Gene Tools, Philomath, OR)
with no targets in zebraﬁsh embryos. For double gene knockdown
experiments, increasing doses of the two MOs were co-injected and
assessed for phenotypic effects: routinely, embryos were co-injected
with 0.4 pmol/embryo of galca-MO and/or 1.4 pmol/embryo of galcb-
MO.
To conﬁrm the targeting efﬁcacy of the two MOs, alternative splicing
pattern analysiswas performed on zebraﬁsh embryos using the following
RT-PCR primers:
galca: forward, 5-cagacttcagccgcagttcatt-3′; reverse, 5′-aagccaccac
tcgtatccac-3′;
galcb: forward, 5′-ttgatggcattggtggatta-3′; reverse, 5′-ctcttcttggctt
ccaccat-3′.
2.11. Quantitative acridine orange apoptosis test
The apoptosis test was performed on 24 hpf embryos as described
[36]. Brieﬂy, dechorionated embryoswere stainedwith 1.0 μg/ml acridine
orange (Sigma). Then, embryos were washed with ﬁsh water, anesthe-
tized in tricaine (ethyl 3-aminobenzoate methanesulfonate salt, Sigma)
and distributed into 96-well plates, ﬁve embryos per well. After lysis in
100% ethanol, ﬂuorescence was measured at λex 490 nm/λem 525 nm
with a microplate reader (Tecan Inﬁnite M200). The apoptosis data
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(ApoTome, Zeiss).2.12. Psychosine analysis
Quantiﬁcation of psychosine (galactosyl-sphingosine plus glucosyl-
sphingosine) was conducted on pools of 100 zebraﬁsh embryos. The
brain of wild type and twitchermice were used as controls. Lyophilized
tissues were homogenized in 120 μl of PBS and lipids were extracted as
reported [37]. Samples were analyzed in a Ultra-Performance Liquid
Chromatography apparatus coupled to an orthogonal acceleration
time-of-ﬂight mass spectrometer with an electrospray ionization inter-
face (LCT Premier, Waters) using gradient program and instrumental
parameters previously described [37]. Datawere acquiredunder positive
(ESI+) ionization mode over a mass range of m/z 50–1800 in W-mode.
A scan time of 0.15 s and interscan delay of 0.01 swere used at a nominal
instrument resolution of 11.500 (FWHM). Leucine enkephalin was usedFig. 1.GALC activity in zebraﬁsh. A, Brain extracts (40 μg of protein) from 4month-old zebraﬁsh
absence or in the presence of a 10-fold molar excess of psychosine (psy) or N-acetyl-D-sphingo
compounds are separated by thin layer chromatography and visualized under an ultraviolet lam
as positive and negative controls, respectively. B, Brain extracts (10 μg of protein) from zebra
4-methylumbelliferyl-β-D-galactoside substrate (1.5 mM) in the presence of 20 μM AgNO3 to i
of the brain extract of zebraﬁsh adults. GALC activity co-sedimentswith the lysosomalβ-hexosam
Inset,Western blot (WB) analysis of the indicatedpooled fractions of thegradient (5 μg of protein
and of the uncleaved 80 kDa protein (arrows) in the dense lysosome-containing fractions. D, E
evaluated for GALC activity using the GALC substrate LRh-6-GalCer. blk, blank reaction in the abas the lock spray calibrant. The detection limit of the method was equal
to 25 pmol of psychosine/g dry tissue.
3. Results
3.1. Identiﬁcation of GALC activity in zebraﬁsh
In order to assess the presence of an enzymatic GALC activity in
zebraﬁsh, a set of preliminary experiments were performed on brain
tissue harvested from 4 month-old zebraﬁsh adults. As shown in Fig. 1A,
B, a signiﬁcant GALC activity was detectable in the zebraﬁsh brain tissue
extract following its incubation with the ﬂuorescent GALC substrate
LRh-6-GalCer [31] or with the 4-methylumbelliferyl-β-D-galactoside sub-
strate, the latter incubation being performed in the presence of 20 μM
AgNO3 to inhibit β-galactosidase activity [30]. In both assays, the extracts
from murine wild-type and twitcher brains were used as positive and
negative controls, respectively. Also, in both assays degradation of the
substrate was competed by a 10-fold molar excess of the GALC substrateadults (zf) were evaluated for GALC activity using the GALC substrate LRh-6-GalCer in the
sine (sph). In this assay, LRh-6-GalCer is converted to LRh-6-Cer and the two ﬂuorescent
p. Brain extracts fromwild-type (wt) andGALC-deﬁcient twitcher (twi−/−)micewereused
ﬁsh adults (zf) and from wt and twi−/− mice were assessed for GALC activity using the
nhibit β-galactosidase activity [30]. C, Subcellular fractionation on Percoll density gradient
inidase enzymemarker (β-hex). Values are representative of 3 independent experiments.
) shows thepresence of an immunoreactive 30 kDa lysosomal-processed enzyme fragment
xtracts (40 μg of protein) from zebraﬁsh embryos at different stages of development were
sence of embryo extract.
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Supplementary Fig. 1A).
In keeping with the enzymatic activity assays, immunohistochemical
analysis of the brain of zebraﬁsh adults showed the presence of a punc-
tate distribution of GALC immunoreactivity in both glial and neuronal
cells (Supplementary Fig. 2). On this basis, to conﬁrm the lysosomal
localization of GALC activity in zebraﬁsh CNS, subcellular fractionation
of brain tissue extract was performed using Percoll density gradient
analysis [32]. Similar to the lysosomal marker β-hexosaminidase, more
than 50% of the total GALC activity present in the brain of zebraﬁsh adults
was recovered in the dense lysosome-containing fractions of the gradient
(fractions 9–10) (Fig. 1C). Accordingly, GALC-immunoreactive bands
corresponding the 30 kDa lysosomal-processed enzyme fragment and
the uncleaved 80 kDa protein ([38] and references therein) were detect-
able by Western blotting in the dense lysosome-containing fractions of
the gradient (Fig. 1C, inset).
To assess thepresence of GALC activity also in zebraﬁsh embryos, the
head region was dissected from embryos at 24, 48 and 72 h post fertil-
ization (hpf) and tissue extracts were incubated with the ﬂuorescent
GALC substrate LRh-6-GalCer. As shown in Fig. 1D, a signiﬁcant GALC
activity was detectable at all the time point investigated.
Together, the data demonstrate the presence of a bona-ﬁde GALC
activity in zebraﬁsh adults and embryos.
3.2. Cloning and characterization of GALC gene orthologs in zebraﬁsh
In order to identify the GALC gene ortholog(s) in zebraﬁsh, the
amino acid sequence of human GALC protein was used as query in a
Blat search performed against the UCSC Genome Browser on Zebraﬁsh
Jul. 2010 (Zv9/danRer7) assembly. Two gene sequences encoding poly-
peptides homologous to human GALC were identiﬁed on zebraﬁsh
chromosomes 20 and 17, named galca (acc. no. NM_001005921) and
galcb (acc. no. NM_213111), respectively. Further bioinformatic analysis
on nucleotide and protein sequences present in the NCBI databases,
performed using the BLAST algorithm, failed to identify additional galc
genes in zebraﬁsh.
Both galca and galcb genes are transcribed as demonstrated by the
presence of 14 and 47 ESTs in the corresponding UniGene clusters,
respectively. Also, RNA-Seqdata frompooled zebraﬁsh tissues, provided
by Wellcome Trust Sanger Institute, suggest that galcb is globally more
expressed than its paralog (data not shown) (PMID: 22798491).
The galca and galcb coding sequences were cloned by RT-PCR from
total RNA isolated from zebraﬁsh embryos at 4 h post fertilization
(hpf). DNA sequencing conﬁrmed that galca and galcb cDNAs encode
for predicted polypeptides of 660 (acc. no. NP_001005921) and 664
(acc. no. NP_998276) amino acids, respectively, with 66% identity and
79% similarity. A comparison of Galca and Galcb polypeptides with
mammalian GALC proteins revealed a high degree of amino acid
sequence identity (61%), with a large number of residue blocks highly
conserved along the primary structure (Supplementary Fig. 3). According
to the Carbohydrate-Active enZYmes Database (CAZY) [39], zebraﬁsh
Galca and Galcb polypeptides belong to the glycoside hydrolase family
59, a class of galactosylcerebrosidase enzymes that includes also
human and mouse GALC.
Zebraﬁsh galca and galcb genes share the same 17 exons/16 introns
structure of human andmurine genes. Regions of conserved synteny are
observed between human chromosome 14, harboring the GALC gene,
and D. rerio chromosomes 17 and 20 (Supplementary Fig. 4A). Also,
duplicated genes other than galc are present on zebraﬁsh chromosomes
17 and 20, suggesting that this region represents one of the remnants of
an ancient genome duplication event that occurred shortly before the
teleost radiation [40]. Interestingly, the analysis of genomic sequences
of other teleosts revealed that Fugu (Takifugu rubripes),Medaka (Oryzias
latipes), Stickleback (Gasterosteus aculeatus) and Tetraodon (Tetraodon
nigroviridis) all possess a single galc gene. A phylogenetic tree of some
vertebrate GALC proteins is shown in Supplementary Fig. 4B.Given the high level of sequence identity between zebraﬁsh Galc
proteins with the mouse orthologous polypeptide, we performed a
homology modeling analysis using the crystal structure of the mouse
GALC protein as template [38]. We obtained two structural models for
D. rerioGalca andGalcb, with a C-score of 0.91 and 0.30 and a calculated
RMSD of 0.84 ± 0.08 and 0.75 ± 0.10, respectively. As expected from
the high protein sequence similarity, the models ﬁt well on the mouse
template when superimposed with PyMOL. Both Galca and Galcb pre-
dicted structures show the presence of the three domains described
formouseGALC [38]: a TIMbarrel domain responsible for the enzymatic
activity, a lectin domain involved in substrate recognition and a β-
sandwich domain (Fig. 2A). Analysis of the protein structures reveals
slightly differences in this latter region that appears to be formed by 6
rather than 7 well-deﬁned β-sheets in Galcb. The position of the four
catalytic residues (T109, E198, E274, R396) and the organization of the
active site are fully conserved (Fig. 2B) as well as the position of the
N-glycosylation site N379 and of the cysteine residues C287 and C394
involved in an intramolecular stabilizing disulphide bond [38]. Also,
amino acids, W307 and T109, that confer substrate speciﬁcity for
galactose- rather than glucose-containing glycolipids, are in topologically
conserved positions. Most of the residues that are not conserved
between mammalian and zebraﬁsh GALC enzymes are exposed on the
surface of the predicted D. rerio structures (data not shown).
In conclusion, our data indicate that galca and galcb are two zebraﬁsh
co-orthologs for themammalianGALC gene and encode for proteinswith
high similarity to their mammalian counterpart.
3.3. Biochemical characterization of zebraﬁsh Galca and Galcb enzymes
In order to characterize the biochemical features of galca and galcb
encoded proteins, human HEK293T cells were stably transfected with
the corresponding cDNAs.Western blot analysiswith a rabbit polyclonal
anti-GALC antibody conﬁrms the increase in the levels of the 30 kDa
immunoreactive lysosomal-processed enzyme fragment ([38] and
references therein) in the cell extracts of both galca- and galcb-
transfected cells when compared to mock-transfected cells (Fig. 3A),
whereas the uncleaved form of the enzyme was below the limits of
detection of the method in all the transfectants. Accordingly, galca and
galcb overexpression leads to a 4–5 fold increase in GALC activity in
transfected cells when compared to mock transfectants (Fig. 3B). For
both transfectants this increase of activity was inhibited by a 10-fold
molar excess of the GALC substrate psychosine but not by control N-
acetyl-D-sphingosine (Supplementary Fig. 1B). Finally, the GALC activity
expressed by galca- and galcb-transfected cells showed a pH optimum
equal to 4.0 (Fig. 3C) and Percoll density gradient analysis conﬁrmed
that most of the activity of both enzymes was recovered in the dense
β-hexosaminidase-positive lysosomal fractions of the gradient (Fig. 3D).
Mannose-6-phosphate (M6P) inhibits the M6P receptor-mediated
cellular uptake of newly-synthesized lysosomal enzymes, leading to
their miss-sorting into the extracellular space [41]. Accordingly, in
keeping with the lysosomal nature of Galca and Galcb proteins, incuba-
tion of HEK293T transfectants with 5 mM M6P leads to lysosomal
enzyme miss-sorting with a signiﬁcant increase in both GALC and β-
hexosaminidase activities present in their conditioned medium when
compared to untreated transfectants (Fig. 3E). Overall, the results
demonstrate that zebraﬁsh galca and galcb genes encode for lysosomal
enzymes endowed with GALC activity.
3.4. Temporal and spatial pattern expression of galca and galcb during
zebraﬁsh development
The expression of galca and galcb genes was investigated during
embryonic and early larvae development in zebraﬁsh by quantitative
RT-PCR and WISH analysis. We took care to design speciﬁc sets of
RT-PCR primers and WISH probes in order to avoid cross-reactivity
between the two galc transcripts. As shown in Fig. 4A, B, galca and galcb
Fig. 2. Structural models of Danio rerio Galca and Galcb proteins obtained by similarity modeling. A, Ribbon diagram of zebraﬁsh Galca (left) and Galcb (right) colored by domain:
β-sandwich (red), TIM barrel (blue), linker (orange), and lectin domain (green). B, Structure of the active site of GALC. The predicted structures of D. rerio Galca, in green, and Galcb, in
blue, were superimposed to the known crystal structure of mouse Galc (pdb: 3zr6), in red. The organization of the active site and the position of catalytic residues T109, E198, E274
and R396 are conserved between mouse and D. rerio co-orthologs. The substrate galactose, placed in the catalytic crevice, is shown in magenta. Substrate speciﬁcity for galactose- rather
than glucose-containing glycolipids is conferred by amino acidsW307 and T109. Numbering of residues is relative to themouse Galc RefSeq protein (NP_032105) and differs of 16 amino
acids from the sequence of mouse GALC structure [38].
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pointing to a maternal origin of both transcripts. Then, the total levels
of galca and galcb mRNAs decreased, to remain constant throughout
development from the 6-somite stage to 48 hpf.
WISH analysis conﬁrmed the expression of both galca and galcb in
zebraﬁsh embryos at 1.25 hpf and 5 hpf (Fig. 4C, D). In the segmentation
period the expression of galca and galcb persists; labeling is detectable
in the rostral part of the embryos in developing CNS whereas the signal
is progressively excluded from the notochord. At 24 hpf, the expression
of both genes is observed in deﬁned areas of the brain, including mid-
brain, midbrain–hindbrain boundary, hindbrain and cerebellum. At
48 hpf, galca and galcb expression is maintained mainly in midbrain–
hindbrain boundary and hindbrain. In allWISH experiments, no speciﬁc
signal was observedwhen embryoswere hybridizedwith a sense probe
(data not shown). Together with the GALC activity data (see Fig. 1D),
these results indicate that galca and galcb are co-expressed from early
stages of CNS development in zebraﬁsh.
3.5. galca/galcb knockdown in zebraﬁsh embryos
To investigate the effect of galca and galcb down-regulation at the
early stages of zebraﬁsh development, we performed loss-of-function
studies using the MO knockdown approach. This results in a transient
silencing of the targeted gene that lasts for the ﬁrst fewdays of develop-
ment [20,21]. To this purpose, speciﬁc MOs were designed to induce
skipping of exon 3 of the immature galca or galcb mRNAs. In both
cases the MOs were predicted to cause the formation of enzymatically
inactive proteins. RT-PCR analysis of single and double galca and galcbmorphants performed at 48 hpf conﬁrmed the targeting efﬁcacy of the
two MOs with galca MO causing both partial and total skipping of
exon 3 and galcb MO causing the complete skipping of exon 3 (data
not shown and Fig. 5A for double galca/galcb morphants). Also, the
total GALC activity present in the protein extract of 24 hpf and 48 hpf
embryos was signiﬁcantly reduced but not abolished by single galca or
galcb knockdown (Fig. 5B). On this basis, the effect of the co-injection
of increasing doses of both MOs was tested for phenotypic effects and
optimum concentrations of 0.4 pmol/embryo and 1.4 pmol/embryo
were used for galca MO and galcbMO, respectively, in all co-injection
experiments. At variance with what observed in single galca or galcb
morphants, the simultaneous injection of galca and galcbMOs resulted
in a complete loss of GALC activity in double galca/galcb morphants
that was paralleled by the disappearance of immunoreactive Galc
protein in the embryo extract (Fig. 5C). In keeping with the transient
nature of MO-mediated gene downregulation [20,21], RT-PCR analysis
performed on zebraﬁsh morphants at 72 hpf showed a partial recovery
in the expression of mature, normally spliced galca and galcb mRNAs
(data not shown). Thus, all the following experiments were performed
within the ﬁrst 48 h after MO injection unless described otherwise.
Constitutive GALC deﬁciency results in the accumulation of the toxic
metabolite psychosine in GLD patients and twitcher mice. To assess
whether the rapid galca/galcb down-regulation that occurs in zebraﬁsh
embryos after MO injectionmay exert a similar effect, wemeasured the
levels of psychosine in the extracts of control and double galca/galcb
morphants by mass spectrometry. The results of the analysis showed
that psychosine (evaluated as galactosyl-sphingosine plus glucosyl-
sphingosine) was undetectable at all the time points investigated
Fig. 3.Biochemical characterization of zebraﬁshGalca andGalcb enzymes inHEK293T transfected cells. A, Total cell extracts (4.0 μg or protein) fromHEK293T cells transfectedwith empty
expression vector (mock) or vectors harboring the zebraﬁsh galca or galcb cDNAwere analyzedbyWesternblottingusing a polyclonal anti-GALC antibody (iGALC);α-tubulinwas used for
normalization. B, The same extracts were assayed for GALC activity at pH 4.0. Values are themean± SDof 5 independent experiments. C, Cell extracts ofmock (Δ), galca (□) and galcb (○)
HEK 293T transfectants were assayed for GALC activity at different pH values of incubation and results are representative of 5 independent experiments. D, Subcellular fractionation on
Percoll density gradient of the cell extracts ofmock (Δ), galca (□) and galcb (○) HEK 293T transfectants. Both Galca and Galcb enzymatic activities co-sediment with the lysosomalβ-hex-
osaminidase enzyme marker (β-hex). Values are representative of 3 independent experiments. E, HEK 293T transfectants were incubated in the absence (black bar) or in the presence
(open bar) of 5 mMmannose-6-phosphate (M6P). After 48 h, cell extracts and conditioned media were assayed for GALC and β-hexosaminidase activities and released activity was cal-
culated as percentage of total activity. Values are the mean ± SD of 5 independent experiments.
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GALC activity knock-down does not result in the accumulation of this
metabolite in zebraﬁsh embryos (Supplementary Fig. 5). Screening for
the presence of psychosines with a long chain base other than sphingo-
sinewas also performed in zebraﬁsh embryos, althoughnonewas present
in morphant extracts (data not shown).
In keepingwith the lack ofmajor phenotypic alterations in heterozy-
gous GLD patients and twitchermice, nomorphological alterationswere
observed in single knockdown galca or galcb zebraﬁsh morphants in
which a signiﬁcant GALC activity was retained. No signiﬁcant macro-
scopic phenotypic alterations occurred also when the complete down-
regulation of GALC activity was achieved by co-injection of both splicing–
inhibiting MOs in the same embryo (data not shown).
To gain insights into possible molecular alterations of CNS following
the double knockdown of galca and galcb genes, we performed WISH
analysis to investigate the expression pattern of various CNS markers
during zebraﬁsh development. We did not observe signiﬁcant alter-
ations of the expression of theneuralmarkerwnt1 [42] andof the cranial
and trunk neural crest marker crestin [43] during somitogenesis in
double galca/galcbmorphants. Also, no signiﬁcant modiﬁcations of the
expression of pax2.1, one of the earliest genes activated during develop-
ment of the midbrain and midbrain–hindbrain boundary [44], and of
emx1, a homeobox gene early expressed in anterior brain [45], occurred
in these embryos (data not shown). In contrast, a reduction and partial
disorganization in the expression of the basic helix–loop–helix tran-
scription factor neuroD [24] was detectable by WISH analysis of the
double galca/galcbmorphants at 24 hpf. In particular, down-regulationof neuroD expressionwas observed in the lateral line ganglia, telenceph-
alon and otic vesicle (20/49 embryos, data not shown). NeuroD expres-
sion was even more compromised when double galca/galcbmorphants
were examined at 48 hpf (Fig. 6A). Indeed, 71% of double morphants
(n = 45) showed an altered neuroD expression pattern versus 11% of
control embryos (n = 66). Co-injection of both splicing-inhibiting
MOs caused in fact a partial or complete down-regulation of neuroD
expression in the hindbrain and midbrain–hindbrain boundary in 22%
of double galca/galcbmorphants with an even more severe phenotype
that included also neuroD down-regulation in the midbrain region in
49% of injected embryos (Fig. 6A). Only minor alterations of neuroD
expression were observed in single galca or galcbmorphants (data not
shown), indicating that a partial reduction in GALC activity results in a
phenotype similar to wild-type embryos. Of note, at variance with
neuroD expression data, no signiﬁcant changes were observed for the
pattern expression of the transcription factor neurogenin-1, an upstream
regulator of neuroD [46] (data not shown).
NeuroD is required for the survival of various subtypes of developing
neurons in the vertebrate CNS [47]. On this basis, a quantitative acridine
orange apoptosis test [36] was performed on double galca/galcb
morphants. As shown in Fig. 6B, GALC activity knockdown results in a
signiﬁcant increase of apoptotic events, mainly localized in the head
region of the embryo. This occurred in the absence of signiﬁcant histo-
logical alterations and lack of globoid cells in the CNS of these embryos
(data not shown). To the best of our knowledge, these data represent
the ﬁrst evidence of early alterations of CNS development following
GALC loss-of-function.
Fig. 4. Embryonic expression pattern of galca and galcb. A, B, Total RNAwas extracted from zebraﬁsh embryos at the indicated developmental stages and analyzed for galca (A) and galcb
(B) expression by quantitative RT-PCR. Averaged data were normalized for 18S RNA expression and plotted on a log2 scale. C–D, WISH analysis of the expression of galca (C) and galcb
(D) genes was performed on zebraﬁsh embryos at different stages of development. Already detectable at 1.25 hpf (8-cells stage), both genes are expressed at the animal pole at 5 hpf
(50% epiboly) where CNS formation originates from ectoderm. galca and galcb transcripts are detectable in the rostral part of the embryo throughout somitogenesis. At 24 hpf, galca
and galcb are co-expressed in different CNS structures including hindbrain,midbrain and cerebellum. CNS co-expression of the two genes is retained at 48 hpf. c, cerebellum; h, hindbrain;
m, midbrain; mhb, midbrain–hindbrain boundary.
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In the present work, we demonstrate the presence of GALC activity
in zebraﬁsh adults and embryos. Accordingly, in silico analysis identiﬁed
two zebraﬁsh genes co-ortholog to mammalian GALC named galca and
galcb as indicated by their conserved synteny and exon/intron organiza-
tion, high amino acid sequence identity and similar predicted protein
structure. When transduced in HEK cells, both genes encode for enzy-
matically active proteinswith lysosomal localization and a pH optimum
equal to 4.0. WISH experiments demonstrated that galca and galcb are
dynamically expressed in CNS during zebraﬁsh development. Already
detectable at 1.25 and 5 hpf, the expression of galca and galcb persists
in developing CNS during the segmentation period whereas the signal is
progressively excluded from the notochord. At 24 hpf, the expression ofboth genes is observed inmidbrain,midbrain–hindbrain boundary, hind-
brain and cerebellum, to be maintained mainly in midbrain–hindbrain
boundary and hindbrain at 48 hpf.
Similar to that observed in heterozygous GLD patients and heterozy-
gous twitchermice, no alterations occurred in single knockdown galca
or galcb zebraﬁsh morphants in which a signiﬁcant GALC activity is
retained. Given the apparent overlapping co-expression of galca and
galcb in zebraﬁsh CNS during development, these data suggest that the
two genesmay encode for proteinswith similar enzymatic and biological
functions and that the residual GALC activity present in the single
morphants is sufﬁcient to guarantee an apparently normal developmen-
tal process in zebraﬁsh embryos. The simultaneous knockdown of galca/
galcb genes resulted instead in the complete down-regulation of GALC
activity in zebraﬁsh embryos. Even though no evident phenotypic
Fig. 5. galca/galcb double knockdown in zebraﬁsh embryos. A, RT-PCR alternative splicing pattern analysis of 48 hpf double galca/galcbmorphants showing the efﬁcacy of the two exon-
skipping MOs when compared to wild-type (WT) embryos. α-Tubulin serves as control. B, Total extracts from wild-type embryos, single galca, single galcb and double galca/galcb
morphants were assayed for GALC activity. Negligible activity was detectable in double galca/galcbmorphants. The results are the mean ± SD of 3 independent experiments. C, No
GALC immunoreactive proteins (iGALC) were found when the extracts of double galca/galcbmorphants (MO) were analyzed byWestern blotting using a polyclonal anti-GALC antibody.
α-Tubulin was used for normalization. ctrl: control murine brain extract.
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caused a signiﬁcant reduction and partial disorganization in the expres-
sion of the basic helix–loop–helix transcription factor neuroD [24] during
CNS development. Alterations of the expression of this neural markerFig. 6. galca/galcb double knockdown affects neuroD expression and apoptosis in zebraﬁsh em
(n = 66) and double galca/galcbmorphants (n = 45) at 48 hpf. NeuroD expression was scored
and hindbrain (dashed bar and panels c, d), and down-regulated in midbrain–hindbrain bound
tative control embryos (a, b) and of double galca/galcbmorphants (c–f). fb, forebrain; h, hindbra
double galca/galcbmorphants were assessed at 24 hpf for apoptotic events by acridine orang
Representative images of the head region of acridine orange-stained control (a) and double gaoccurred in CNS regions of zebraﬁsh embryo in which both galca and
galcb are highly expressed, including midbrain, midbrain–hindbrain
boundary and hindbrain. At variance, only minor modiﬁcations, if any,
were observed in these embryos for the neural marker wnt1 [42], thebryos. A, The expression of the neural marker neuroD was analyzed by WISH in control
as normal (open bar and panels a, b), down-regulated in midbrain–hindbrain boundary
ary, midbrain and hindbrain (black bar and panels e, f). Lateral and top view of represen-
in;mhb,midbrain–hindbrain boundary;m,midbrain. B, Untreated (un.), control (ctrl.) and
e staining followed by measurement of total ﬂuorescence in embryo extracts (n = 30).
lca/galcbmorphant (b) embryos. *, P b 0.05, Student's t test.
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midbrain–hindbrain boundary gene pax2.1 [44], the early anterior
brain homeobox gene emx1 [45], and the upstream neuroD regulator
neurogenin-1 [46]. This indicates that the selective down-regulation of
neuroD expression observed during CNS development does not repre-
sent the mere consequence of non-speciﬁc neurotoxic effects conse-
quent to galca/galcb loss-of-function. Even though further experiments
are required to investigate the role of GALC in the modulation of neuroD
expression, our data indicate that the complete down-regulation of GALC
activity in double galca/galcbmorphantsmay result in signiﬁcant changes
of CNS development in zebraﬁsh. Indeed, we observed an increase of
apoptotic events in the head region of double galca/galcbmorphants, in
keeping with the premature neuronal death that occurs at early stages
of neurogenesis in NeuroD null mice [47].
Lysosomal storage disorders are characterized by the accumulation
of disease-speciﬁc metabolic intermediates [2]. The pathogenesis of
GLD has been proposed to arise from the accumulation of psychosine,
the neurotoxic lysolipid metabolite detected at high levels in the CNS
of GLD patients [2–4]. Accumulation of psychosine leads to cytotoxic
effects onoligodendroglial cells andprogressive demyelination, triggering
apoptotic cell death [48–50] and resulting in a severe neurological
dysfunction [5–7]. However, no psychosine was detectable by mass
spectrometry analysis of the embryo extracts of double galca/galcb
morphants at all the time points investigated. Likely, the limited period
of galca/galcb knockdown dictated by the transient inhibitory effect
exerted by MOs [20,21] did not allow a signiﬁcant accumulation of
psychosine in zebraﬁsh embryos. Relevant to this point, oligodendrocyte-
driven CNS myelination in zebraﬁsh starts in the hindbrain at day 4 of
development and it is not yet completed at day 10 [51], making the
study of the effect of GALC activity knockdown on myelination in
zebraﬁsh morphants unfeasible.
Even though the above limitations indicate that double galca/galcb
zebraﬁsh morphants do not represent a model of advanced human
GLD, the observed alterations of neuroD expression in these embryos,
paralleled by an increase of apoptotic events, indicate that GALC loss-
of-function may have early pathological consequences independent of
psychosine accumulation, thus providing novel insights into the patho-
genesis of GLD. This possibility is supported by a recent study about the
impact of a spontaneousmissenseGalcmutation in twi-5Jmice inwhich
psychosine levels do not correlate with nervous system regions
exhibiting demyelination and axonopathy [52]. Thus, double galca/
galcb zebraﬁshmorphants represent an attractive option for addressing
previously unrecognized psychosine-independent key aspects of the
pathogenesis of GLD. Further studies will be required to assess the
impact of galca/galcb down-regulation on the sphingolipid proﬁle in
zebraﬁsh embryos and to elucidate the molecular mechanism(s)
responsible for the observed alterations in neuroD expression that follow
the loss of GALC activity.
Given the limited progresses toward an efﬁcacious clinical treatment
of GLD patients [7,8], novel model systems may provide an invaluable
tool for investigating the molecular mechanisms underlying GLD in
the search for effective therapeutic interventions. At present, murine
models of GLD are widely used to understand the molecular and
biochemical bases of the disease and for the search of novel therapeutic
approaches [9–12,52]. Nevertheless, such studies in mice can be rela-
tively slow, laborious and expensive to perform. Also, the intrauterine
gestation makes it difﬁcult to follow possible alterations in early devel-
opmental processes as a consequence of the lack of GALC activity. To this
respect, zebraﬁsh have signiﬁcant advantages over mice in producing
hundreds of externally fertilized eggs that develop in vitro as optically
transparent embryos, allowing live manipulations and observations
from the earliest stages of development. Our ﬁndings underscore the
potentiality of the zebraﬁsh system in studying the pathogenesis of
lysosomal neurodegenerative diseases, including GLD. The lack of lethal
embryonic defects in zebraﬁsh galca/galcbmorphants pave the way for
generating stable galca/galcb single and double gene knock-outzebraﬁsh lines by TALEN or CRISPR/Cas targeting technology [22,23].
These zebraﬁsh lines will provide further insights for the development
of novel GLD animalmodels and for the search of efﬁcacious therapeutic
strategies.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2014.01.008.
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